NGS-based Solution Makes Fast, Highly Accurate, Cost-effective Noninvasive Prenatal Testing Available to EU Labs SAN DIEGO—-Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the VeriSeq™ NIPT Solution, a CE-IVD marked next-generation sequencing (NGS)-based approach to noninvasive prenatal testing (NIPT), including CE-IVD marked library prep and analysis software, which enables laboratories in the European Union […]

Expansion is Supported by four Broad Patents for Company’s Leap-In Transposase® Technology (Newark, CA) ATUM (formerly DNA2.0) has announced an expansion of its services to include cell line development, which has been enabled by the company’s proprietary Leap-In Transposase genome engineering tools.  ATUM has also begun construction of a new, 7,000 SF mammalian cell engineering […]

San Carlos, California NuGEN Technologies, Inc. today announces the launch of two new products, Universal Plus mRNA-Seq and Trio RNA-Seq kits that enable RNA-Seq analyses from routine samples to those isolated from sources like cfRNA and FFPE which normally produce rare or low quality nucleic acids. Universal Plus mRNA-Seq is a comprehensive solution for mRNA […]

Lucigen Corporation announces it has signed a global agreement with Illumina, Inc. for Lucigen to be the sole distributor of Epicentre Technologies’ genomics kits, enzymes and ancillary reagents. Products covered by this new agreement are in addition to the select Epicentre products that were licensed and transferred to Lucigen for manufacture and distribution in December […]

Nexus Copy Number 9.0 expands support for a wider array of NGS technologies, supporting low-pass sequencing and targeted panels as well as normal coverage WES and WGS for copy number analysis while continuing to provide an extensive list of statistical analysis and visualization tools to perform large cohort studies. El Segundo, CA BioDiscovery’s Nexus Copy […]

WASHINGTON – AACR 2017 — Paragon Genomics, a life science company dedicated to improving the critical upfront target enrichment and library preparation workflow for Next-Generation Sequencing, is launching its CleanPlex™ target enrichment solution. It is a patented amplicon sequencing technology, debuting at AACR Annual Meeting 2017 together with its CleanPlex™ OncoZoom Panel covering the hotspots of 65 key oncogenes, panels covering the entire coding regions of specific genes […]

SAN DIEGO—- Illumina, Inc. (NASDAQ: ILMN) today announced it is contributing more than 8,000 associations of somatic genetic alterations–variants linked to tumors–to the Clinical Interpretation of Variants in Cancer (CIViC) resource, an openly accessible database hosted by Washington University in St. Louis that can be used in precision medicine. Illumina’s donation triples the number of […]

Strand NGS 3.0 release with processing improvements promise 2x speedup compared to the global benchmark Bangalore, India Strand Life Sciences today announced the release of version 3.0 of its flagship, next-generation sequencing (NGS) data analysis and visualization platform, Strand NGS. Benchmarked against the world’s best, major enhancements in this release have led to significant improvements […]

Broad spectrum of technological advances for cancer research on display at AACR 2017 WASHINGTON, D.C.–AACR 2017 – Thermo Fisher Scientific, the world leader in serving science, will highlight its latest innovative solutions for research designed to help customers advance the future of precision medicine. The new products and a wide spectrum of scientific posters will […]

Focus on Technological Advances in Genomics and Cellular Analysis SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced it will showcase some of its most recent technological advances in the areas of cell analysis and genomics at the AACR Annual Meeting 2017, being held April 1 – 5, 2017 in Washington, D.C. Agilent will […]